CBL expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.31410446360769E-11 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.35930000000339E-06 |
Normal-vs-Stage2 |
9.839900E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.210320E-02 |
Stage1-vs-Stage2 |
7.756400E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
6.266600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.280000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.81450007533613E-10 |
Normal-vs-AfricanAmerican |
2.940600E-01 |
Normal-vs-Asian |
9.19289999679052E-08 |
Caucasian-vs-AfricanAmerican |
6.620000E-02 |
Caucasian-vs-Asian |
8.942000E-01 |
AfricanAmerican-vs-Asian |
5.266800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.3627000000046E-05 |
Normal-vs-Female |
2.29139999974315E-07 |
Male-vs-Female |
2.881400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.595500E-03 |
Normal-vs-Extreme_Weight |
3.93570000001287E-06 |
Normal-vs-Obese |
2.102900E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.392000E-01 |
Normal_Weight-vs-Obese |
8.687500E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.003200E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.035800E-01 |
Normal-vs-Age(41-60Yrs) |
6.821800E-04 |
Normal-vs-Age(61-80Yrs) |
6.66239999835838E-08 |
Normal-vs-Age(81-100Yrs) |
4.725800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.760970E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.981900E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.900820E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.517800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.162400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.781010E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
1.270810E-01 |
Normal-vs-Grade 3 |
6.398400E-02 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.462200E-01 |
Grade 2-vs-Grade 4 |
1.270810E-01 |
Grade 3-vs-Grade 4 |
6.398400E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.67109999674275E-08 |
Normal-vs-N1 |
1.438200E-02 |
N0-vs-N1 |
1.141970E-01 |
|
|